Xuewei Bai

2.0k total citations
49 papers, 1.3k citations indexed

About

Xuewei Bai is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Xuewei Bai has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 23 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Xuewei Bai's work include Pancreatitis Pathology and Treatment (17 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Phagocytosis and Immune Regulation (5 papers). Xuewei Bai is often cited by papers focused on Pancreatitis Pathology and Treatment (17 papers), Pancreatic and Hepatic Oncology Research (16 papers) and Phagocytosis and Immune Regulation (5 papers). Xuewei Bai collaborates with scholars based in China, United States and Sweden. Xuewei Bai's co-authors include Bei Sun, Yue Gao, Shangha Pan, Rui Kong, Dongbo Xue, Hua Chen, Hongchi Jiang, Shangha Pan, Gang Wang and Guangquan Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Hepatology.

In The Last Decade

Xuewei Bai

47 papers receiving 1.3k citations

Peers

Xuewei Bai
Lihui Wei China
Jie Jiang China
Akihiro Muto Japan
Le Zhao China
Wendong Wang China
Xingfeng Yin China
Edit Mikó Hungary
Di Zhang China
Dong‐Yan Shen China
Lihui Wei China
Xuewei Bai
Citations per year, relative to Xuewei Bai Xuewei Bai (= 1×) peers Lihui Wei

Countries citing papers authored by Xuewei Bai

Since Specialization
Citations

This map shows the geographic impact of Xuewei Bai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Bai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Bai more than expected).

Fields of papers citing papers by Xuewei Bai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Bai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Bai. The network helps show where Xuewei Bai may publish in the future.

Co-authorship network of co-authors of Xuewei Bai

This figure shows the co-authorship network connecting the top 25 collaborators of Xuewei Bai. A scholar is included among the top collaborators of Xuewei Bai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuewei Bai. Xuewei Bai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Nagaoka, Katsuya, Xuewei Bai, Dan Liŭ, et al.. (2023). Elevated 2-oxoglutarate antagonizes DNA damage responses in cholangiocarcinoma chemotherapy through regulating aspartate beta-hydroxylase. Cancer Letters. 580. 216493–216493. 4 indexed citations
3.
Bai, Xuewei, Yanmei Zhou, Yuki Yokota, et al.. (2022). Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade. Journal of Experimental & Clinical Cancer Research. 41(1). 132–132. 54 indexed citations
4.
Zhang, Guangquan, Wenbo Yang, Hongze Chen, et al.. (2021). Lnc-PFAR facilitates autophagy and exacerbates pancreatic fibrosis by reducing pre-miR-141 maturation in chronic pancreatitis. Cell Death and Disease. 12(11). 996–996. 24 indexed citations
5.
Zhao, Tong, Yilong Li, Xinjian Li, et al.. (2021). Integrating Genetic and Transcriptomic Data to Reveal Pathogenesis and Prognostic Markers of Pancreatic Adenocarcinoma. Frontiers in Genetics. 12. 747270–747270. 2 indexed citations
6.
Li, Guanqun, Tao Zhang, Peng Xiao, et al.. (2020). Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective study. Cell Death Discovery. 6(1). 94–94. 16 indexed citations
7.
Nagaoka, Katsuya, et al.. (2020). Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis. Digestive Diseases and Sciences. 66(4). 1080–1089. 8 indexed citations
8.
Ji, Mengyao, Jingmei Hu, Xuewei Bai, et al.. (2020). Snake Cathelicidin Derived Peptide Inhibits Zika Virus Infection. Frontiers in Microbiology. 11. 1871–1871. 20 indexed citations
9.
Nagaoka, Katsuya, Xuewei Bai, Kosuke Ogawa, et al.. (2019). Anti-tumor activity of antibody drug conjugate targeting aspartate-β-hydroxylase in pancreatic ductal adenocarcinoma. Cancer Letters. 449. 87–98. 19 indexed citations
10.
Lin, Qiushi, Xuesong Chen, Fanzheng Meng, et al.. (2019). ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Molecular Cancer. 18(1). 156–156. 66 indexed citations
11.
Hou, Guofang, et al.. (2018). Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update. Bosnian Journal of Basic Medical Sciences. 18(4). 297–304. 32 indexed citations
12.
Chen, Hongze, Liang Ji, Le Li, et al.. (2017). Early prediction of infected pancreatic necrosis secondary to necrotizing pancreatitis. Medicine. 96(30). e7487–e7487. 33 indexed citations
13.
Liu, Weihui, Yan Chen, Xuewei Bai, et al.. (2016). Identification and characterization of a novel neuropeptide (neuropeptide Y-HS) from leech salivary gland of Haemadipsa sylvestris. Chinese Journal of Natural Medicines. 14(9). 677–682. 11 indexed citations
14.
Li, Le, Guangquan Zhang, Hua Chen, et al.. (2016). Risk factors analysis of benign and malignant pancreatic cystic neoplasm and prognosis. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 15(6). 562–566.
15.
Mo, Guoxiang, Xuewei Bai, Zongjie Li, et al.. (2014). A Novel Insulinotropic Peptide from the Skin Secretions of Amolops loloensis Frog. Natural Products and Bioprospecting. 4(5). 309–313. 6 indexed citations
16.
Lv, Jiachen, et al.. (2014). Lycopene protects pancreatic acinar cells against severe acute pancreatitis by abating the oxidative stress through JNK pathway. Free Radical Research. 49(2). 151–163. 24 indexed citations
17.
18.
Cheng, Zhuoxin, Bei Sun, Shuangjia Wang, et al.. (2011). Nuclear Factor-κB–Dependent Epithelial to Mesenchymal Transition Induced by HIF-1α Activation in Pancreatic Cancer Cells under Hypoxic Conditions. PLoS ONE. 6(8). e23752–e23752. 76 indexed citations
19.
Wang, Shuangjia, Bei Sun, Zhuoxin Cheng, et al.. (2011). Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Cancer Chemotherapy and Pharmacology. 68(6). 1421–1430. 70 indexed citations
20.
Chen, Hua, Bei Sun, Shuangjia Wang, et al.. (2009). Growth inhibitory effects of dihydroartemisinin on pancreatic cancer cells: involvement of cell cycle arrest and inactivation of nuclear factor-κB. Journal of Cancer Research and Clinical Oncology. 136(6). 897–903. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lihui Wei Breakdown of academic impact, for papers by Jie Jiang Breakdown of academic impact, for papers by Akihiro Muto Breakdown of academic impact, for papers by Le Zhao Breakdown of academic impact, for papers by Wendong Wang Breakdown of academic impact, for papers by Xingfeng Yin Breakdown of academic impact, for papers by Edit Mikó Breakdown of academic impact, for papers by Di Zhang Breakdown of academic impact, for papers by Dong‐Yan Shen
Rankless by CCL
2026